In line with the previous results, co-administration of pravastatin improved vascular integration and functional recovery, confirming the therapeutic potential of statin-mediated eNOS/NO pathway activation in reversing obesity-induced endothelial dysfunction. This evidence concerns the gene NOS3 and obesity due to melanocortin 4 receptor deficiency.